Antibody level against COVID-19 among the vaccinated infected and non-infected doctors by SARS-COV-2: A Comparative study
Introduction: A novel coronavirus (2019-nCoV or SARS-CoV-2) emerged at the end of 2019 in Wuhan, Hubei province, China named as COVID-19. IgM, the first antibody produced by the body, is generated gradually 1 week after symptom onset and declines by 4 weeks after the COVID infection. In this backgro...
Saved in:
Main Authors: | Nazma Akhter (Author), Forhadul Hoque Mollah (Author), Nowrose Jahan (Author), Jurdi Adam (Author), Md Arif Hossain (Author), Md Zaforullah Chowdhury (Author) |
---|---|
Format: | Book |
Published: |
Update Dental College,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts
by: Md Shakeel Ahmed, et al.
Published: (2023) -
Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
by: Lorenza Romani, et al.
Published: (2022) -
Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications
by: Md. Kaderi Kibria, et al.
Published: (2024) -
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
by: Ruth Connor, et al.
Published: (2024) -
Temporal profile of specific antibody against SARS-CoV-2 among infected people: a literature study
by: Wen WU, et al.
Published: (2022)